LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Integer Holdings Corporation ("Integer†or the "Company†) (NYSE: ITGR) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON INTEGER (ITGR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On October 2. ...

NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR) securities between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”). The Complaint alleges that Defendants failed to disclose that: (i) the Co ...

Core Viewpoint - A securities fraud class action lawsuit has been filed against Integer Holdings Corporation and certain executives, alleging misleading statements and failure to disclose adverse facts about the company's business and operations during the class period from July 25, 2024, to October 22, 2025 [1] Company Overview - Integer Holdings Corporation, based in Plano, Texas, is one of the largest medical device contract development and manufacturing organizations globally, focusing on cardiac rhythm management and cardiovascular medical devices [2] - Approximately 60% of Integer's total revenue is generated from its cardiovascular product line, which includes electrophysiology devices that diagnose and map the heart's electrical activity [2] Industry Context - Prior to the class period, the electrophysiology device market experienced a technological revolution with the development of pulse field ablation procedures, which treat atrial fibrillation [3] - The integration of electrophysiology devices and pulse field ablation platforms became a significant growth driver for Integer's cardiovascular segment [3] Allegations in the Class Action - The lawsuit claims that during the class period, Integer's executives made materially false and misleading statements regarding the company's competitive position and sales performance in the electrophysiology market [4] - Specific allegations include: 1. Integer overstated its competitive position in the EP manufacturing market 2. The company experienced a deterioration in sales for two of its EP devices, contrary to claims of strong customer demand 3. Integer mischaracterized its EP devices as a long-term growth driver for its cardiovascular segment [4] Disclosure of Financial Performance - On October 23, 2025, Integer disclosed a lowered full-year 2025 sales guidance of $1.840 billion to $1.854 billion, which was below analysts' expectations [5] - The company projected net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026, with expectations of declining sales for three new products, including two electrophysiology products [5] - Following this disclosure, Integer's stock price fell by $35.22, or over 32%, from $109.11 to $73.89 per share [5]

Question-and-Answer SessionI want to start off big picture. You've had a CEO transition recently, you did notice, I know. But I'd love if you could just sort of step back and talk about what you see coming in. Some might call it a rocky start, you might call it an opportunity, but I'm going to leave that for you to label.Payman KhalesCEO, President & Director Yes. Thank you for that, and thanks for having us. It's great to be here. I certainly see this as an opportunity, and I'm very bullish about our busin ...

Integer (NYSE:ITGR) FY 2025 Conference December 03, 2025 09:45 AM ET Company ParticipantsDiron Smith - CFOPayman Khales - CEOConference Call ParticipantsNone - AnalystNoneI am meant to be specific. There are a lot of healthcare analysts walking around here. I am here with the management. Oh, goodness.You need a mic.All right.I'm still Joanne, and I'm still here with the management of Integer. I'm very, very thrilled that both of you are joining us. Thank you. I want to start off big picture. You've had a CE ...

Integer (NYSE:ITGR) FY 2025 Conference December 03, 2025 09:45 AM ET Company ParticipantsDiron Smith - CFOPayman Khales - CEOConference Call ParticipantsNone - AnalystNoneI am meant to be specific. There are a lot of Healthcare Analysts walking around here. I am here with the management. Oh, goodness.You need a mic.All right.I'm still Joanne, and I'm still here with the management of Integer. I'm very, very thrilled that both of you are joining us. Thank you. I want to start off big picture. You've had a CE ...

Integer (NYSE:ITGR) FY 2025 Conference December 03, 2025 09:45 AM ET Speaker2I am meant to be specific. There are a lot of healthcare analysts walking around here. I am here with the management. Oh, goodness.You need a mic.All right.I'm still Joanne, and I'm still here with the management of Integer. And I'm very, very thrilled that both of you are joining us. So thank you. I want to start off big picture. You've had a CEO transition recently.Speaker3Yes.You didn't notice, I know. But I'd love if you could ...

Integer (NYSE:ITGR) FY Conference December 02, 2025 08:00 AM ET Company ParticipantsDiron Smith - CFOPayman Khales - CEOConference Call ParticipantsMatt O'Brien - AnalystMatt O'BrienAll righty. Good morning, everybody. Thank you so much for joining us and coming out to the Piper Sandler Healthcare Conference. My name is Matt O'Brien. I'm one of the med tech analysts here at Piper. Integer is going to start us off here this morning from the company. We've got Payman, who's the CEO, and Diron, who's the CFO o ...

Core Insights - Integer Holdings Corporation (NYSE: ITGR) is a leading medical device contract development and manufacturing organization, focusing on enhancing patient lives through innovative products and solutions [3]. Company Overview - Integer Holdings Corporation is one of the largest CDMO in the world, serving markets such as cardiac rhythm management, neuromodulation, and cardio and vascular [3]. - The company operates under well-known brands including Greatbatch Medical and Lake Region Medical [3]. Upcoming Events - The executive leadership team will participate in the Piper Sandler 37th Annual Healthcare Conference on December 2, 2025, at 8:00 a.m. ET [5]. - Additionally, they will attend Citi's 2025 Global Healthcare Conference on December 3, 2025, at 9:45 a.m. ET [5]. - Live webcasts and replays of these events will be available on the Investor Relations section of the Integer website [1].

Core Insights - The article discusses the importance of enabling Javascript and cookies in browsers to ensure proper functionality and access to content [1] Group 1 - The article emphasizes that users may be blocked from proceeding if an ad-blocker is enabled [1]